pentoxifylline has been researched along with Arteriosclerosis Obliterans in 23 studies
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A study was carried out in 17 patients with arteriosclerosis obliterans to assess the effectiveness of treatment with pentoxifylline ('Trental') and to investigate its possible mechanism of action." | 9.05 | Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action. ( Bieroń, K; Dembińska-Kieć, A; Grodzińska, L; Gryglewski, RJ; Kostka-Trabkowa, E, 1985) |
| "Pentoxifylline (PTX) has a well-known therapeutic effect in vascular diseases, which is based on the rearrangement of blood cell cytoskeleton and thus increased microcirculatory flow." | 5.28 | Effect of pentoxifylline on decreased in vitro mononuclear leucocyte chemotaxis in vascular and polysystemic autoimmune diseases. ( Bedö, Z; Sonkoly, I; Szabó, G; Szegedi, G; Szekanecz, Z, 1991) |
| "A study was carried out in 17 patients with arteriosclerosis obliterans to assess the effectiveness of treatment with pentoxifylline ('Trental') and to investigate its possible mechanism of action." | 5.05 | Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action. ( Bieroń, K; Dembińska-Kieć, A; Grodzińska, L; Gryglewski, RJ; Kostka-Trabkowa, E, 1985) |
| "Pentoxifylline (PTX) has a well-known therapeutic effect in vascular diseases, which is based on the rearrangement of blood cell cytoskeleton and thus increased microcirculatory flow." | 1.28 | Effect of pentoxifylline on decreased in vitro mononuclear leucocyte chemotaxis in vascular and polysystemic autoimmune diseases. ( Bedö, Z; Sonkoly, I; Szabó, G; Szegedi, G; Szekanecz, Z, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (52.17) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernát, SI | 1 |
| Tryniszewski, W | 1 |
| Nowak, D | 1 |
| Brocki, M | 1 |
| Maziarz, Z | 1 |
| Rysz, J | 1 |
| Landi, A | 1 |
| Koshkin, VM | 2 |
| Stoĭko, IuM | 1 |
| Strano, A | 1 |
| Davì, G | 1 |
| Novo, S | 1 |
| Avellone, G | 1 |
| Pinto, A | 1 |
| Szekanecz, Z | 2 |
| Szabó, G | 2 |
| Sonkoly, I | 2 |
| Bedö, Z | 2 |
| Szegedi, G | 2 |
| Jakab, L | 1 |
| Karandashov, VI | 1 |
| Petukhov, EB | 1 |
| Zrodnikov, VS | 1 |
| Leont'eva, NV | 1 |
| Belotserkovskiĭ, MV | 1 |
| Rostova, NS | 1 |
| Zolotnitskaia, VP | 1 |
| Leont'ev, SA | 1 |
| Dmitrieva, IaV | 1 |
| Dmitrieva, LA | 1 |
| Belousov, IuB | 1 |
| Savenkov, PM | 1 |
| Sidel'man, AA | 1 |
| Parfenov, AS | 1 |
| Savenkov, MP | 1 |
| Cavaller, JM | 1 |
| Samper, JC | 1 |
| Regenthal, R | 1 |
| Voigt, H | 2 |
| Reuter, W | 2 |
| Preiss, R | 1 |
| Ovchinnikov, VA | 1 |
| Parakhoniak, NV | 1 |
| Zubova, TA | 1 |
| Chyzy, R | 1 |
| Lukjan, H | 1 |
| Rość, D | 1 |
| Bielawiec, M | 1 |
| Sawicka, J | 1 |
| Beykirch, H | 1 |
| Herrmann, W | 1 |
| Poggesi, L | 1 |
| Boddi, M | 1 |
| Scarti, L | 1 |
| Masotti, G | 1 |
| Di Perri, T | 1 |
| Kuczyńska, K | 1 |
| Zebrowski, M | 2 |
| Kancelarczyk, WL | 2 |
| Rymaszewski, Z | 1 |
| Berent, H | 1 |
| Uchman, B | 1 |
| Atroshchenko, ES | 1 |
| Kostka-Trabkowa, E | 1 |
| Dembińska-Kieć, A | 1 |
| Grodzińska, L | 1 |
| Bieroń, K | 1 |
| Gryglewski, RJ | 1 |
2 reviews available for pentoxifylline and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Secondary prevention and conservative therapy of obliterative arteriosclerosis].
Topics: Arteriosclerosis Obliterans; Cilostazol; Clinical Trials as Topic; Epoprostenol; Exercise; Hematolog | 2004 |
[Treatment of vascular diseases of the extremities using pentoxifylline].
Topics: Aminophylline; Arteriosclerosis Obliterans; Clinical Trials as Topic; Drug Evaluation; Humans; Inter | 1988 |
8 trials available for pentoxifylline and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Effectiveness of pentoxifylline and of bio-electromagnetic therapy in lower limb obliterative arterial disease].
Topics: Aged; Aged, 80 and over; Arteriosclerosis Obliterans; Combined Modality Therapy; Electromagnetic Phe | 2013 |
[Effect of pentoxifylline preparations and photohemotherapy with blue light on the blood viscosity].
Topics: Aged; Arteriosclerosis Obliterans; Blood Viscosity; Combined Modality Therapy; Female; Hematologic A | 1998 |
[Pharmacotherapy of peripheral arteriosclerosis].
Topics: Aged; Arteriosclerosis; Arteriosclerosis Obliterans; Azepines; Clinical Trials as Topic; Drug Evalua | 1978 |
[Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Drug Evaluation; Female; Humans; | 1976 |
[The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
Topics: Adult; Arteriosclerosis Obliterans; Blood Viscosity; Fibrinogen; Humans; Intermittent Claudication; | 1991 |
[Treatment of vascular diseases of the extremities using pentoxifylline].
Topics: Aminophylline; Arteriosclerosis Obliterans; Clinical Trials as Topic; Drug Evaluation; Humans; Inter | 1988 |
[Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Humans; Hypolipidemic Agents; Le | 1988 |
Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.
Topics: Adenosine Diphosphate; Adult; Aged; Arteriosclerosis Obliterans; Blood Coagulation Tests; Clinical T | 1985 |
14 other studies available for pentoxifylline and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
Influence of pharmacological treatment on blood flow and muscle perfusion in patients with obliterative atheromatosis assessed with isotopic methods. A pilot study.
Topics: Analysis of Variance; Arteriosclerosis Obliterans; Aspirin; Blood Flow Velocity; Exercise; Female; H | 2010 |
[Efficacy of a new pentoxifilline form-vasonit retard in the treatment of patients with obliterating diseases of the lower limbs arteries].
Topics: Arteriosclerosis Obliterans; Delayed-Action Preparations; Female; Humans; Lower Extremity; Male; Mid | 2005 |
[Conservative treatment of lower limb chronic obliterative atherosclerosis: strategy and tactics].
Topics: Arteriosclerosis Obliterans; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Fibrinolyt | 2005 |
[Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
Topics: Aged; Arteriosclerosis Obliterans; Blood Pressure; Blood Viscosity; Brain Ischemia; Drug Evaluation; | 1981 |
[Favorable in vitro effect of pentoxifylline on damaged lymphocyte migration in arteriosclerosis obliterans and systemic lupus erythematosus].
Topics: Arteriosclerosis Obliterans; Autoimmune Diseases; Chemotaxis; Humans; In Vitro Techniques; Leukocyte | 1993 |
[Pentoxyphylline and lymphocyte migration].
Topics: Arteriosclerosis Obliterans; Autoimmune Diseases; Cell Movement; Humans; Lymphocytes; Pentoxifylline | 1993 |
[Photo-hemo-correction in the complex treatment of patients with obliterating atherosclerosis of the arteries of the lower limbs].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arteriosclerosis Obliterans; Blood; Blood Vessel Prosth | 2000 |
Effect of pentoxifylline on decreased in vitro mononuclear leucocyte chemotaxis in vascular and polysystemic autoimmune diseases.
Topics: Adult; Arteriosclerosis Obliterans; Autoimmune Diseases; Chemotaxis, Leukocyte; Female; Humans; In V | 1991 |
[Status and correction of regional lipid metabolism in atherosclerosis obliterans of the arteries of the lower extremities].
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis Obliterans; Dextrans; Drug Combinations; Heparin; H | 1987 |
Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arteriosclerosis Obliterans; Cyclic AMP; Erythrocyte Deformabili | 1987 |
[Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
Topics: Arteriosclerosis Obliterans; Hemodynamics; Humans; Ischemia; Leg; Lipids; Male; Middle Aged; Nifedip | 1989 |
[Pentoxifylline and prostaglandins].
Topics: 6-Ketoprostaglandin F1 alpha; Arteriosclerosis Obliterans; Blood Platelets; Cyclic AMP; Endothelium, | 1988 |
[Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Leg | 1988 |
[Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries].
Topics: Adult; Arteriosclerosis Obliterans; Cardiac Output; Hemodynamics; Humans; Iodine Radioisotopes; Male | 1986 |